0001645113-23-000009.txt : 20230109 0001645113-23-000009.hdr.sgml : 20230109 20230109182159 ACCESSION NUMBER: 0001645113-23-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leonard Frank X CENTRAL INDEX KEY: 0001822879 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 23519235 MAIL ADDRESS: STREET 1: 20 VALLEY STREAM PARKWAY, STREET 2: SUITE 300 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_167330650457668.xml FORM 4 X0306 4 2023-01-05 0 0001645113 NovoCure Ltd NVCR 0001822879 Leonard Frank X C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 0 1 0 0 President, CNS Cancers US Ordinary Shares 2023-01-05 4 S 0 2345 119.0077 D 48111 D Ordinary Shares 2023-01-05 4 S 0 417 108 D 47694 D Ordinary Shares 2023-01-05 4 S 0 526 115.0348 D 47168 D Ordinary Shares 2023-01-05 4 S 0 1010 117 D 46158 D Ordinary Shares 2023-01-05 4 M 0 7826 14.37 A 53984 D Ordinary Shares 2023-01-05 4 S 0 7826 108 D 46158 D Ordinary Shares 2023-01-05 4 M 0 7500 11.46 A 53658 D Ordinary Shares 2023-01-05 4 S 0 7500 108 D 46158 D Ordinary Shares 2023-01-05 4 M 0 5517 7.15 A 51675 D Ordinary Shares 2023-01-05 4 S 0 5517 108 D 46158 D Ordinary Shares 2023-01-05 4 M 0 7183 21.15 A 53341 D Ordinary Shares 2023-01-05 4 S 0 7183 114.0001 D 46158 D Ordinary Shares 2023-01-05 4 M 0 7183 21.15 A 53341 D Ordinary Shares 2023-01-05 4 S 0 7183 120 D 46158 D Options to Buy Ordinary Shares 14.37 2023-01-05 4 M 0 7826 0 D 2025-02-23 Ordinary Shares 7826.0 0 D Options to Buy Ordinary Shares 11.46 2023-01-05 4 M 0 7500 0 D 2026-02-24 Ordinary Shares 7500.0 0 D Options to Buy Ordinary Shares 7.15 2023-01-05 4 M 0 5517 0 D 2027-02-21 Ordinary Shares 5517.0 0 D Options to Buy Ordinary Shares 21.15 2023-01-05 4 M 0 7183 0 D 2028-02-26 Ordinary Shares 7183.0 10479 D Options to Buy Ordinary Shares 21.15 2023-01-05 4 M 0 7183 0 D 2028-02-26 Ordinary Shares 7183.0 17662 D On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 2,345 shares in multiple trades at prices ranging from $119.00 to $119.07. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard. On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 526 shares in multiple trades at prices ranging from $115.00 to $115.59. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 7,183 shares in multiple trades at prices ranging from $114.00 to $114.03. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Fully vested as of the date hereof. By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard 2023-01-09